Phase 3, Open-Label Extension Study of AMBTX-01 (Neridronate) for Complex Regional Pain Syndrome Type 1

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
A Phase 3 open-label extension study of AMBTX-01 (neridronate) for Complex Regional Pain Syndrome Type 1
Epistemonikos ID: 9a1606ff2e816134f00c532b58aff71025551194
First added on: Oct 06, 2026